These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 11726969)
1. Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis. Lei B; DeLeo FR; Hoe NP; Graham MR; Mackie SM; Cole RL; Liu M; Hill HR; Low DE; Federle MJ; Scott JR; Musser JM Nat Med; 2001 Dec; 7(12):1298-305. PubMed ID: 11726969 [TBL] [Abstract][Full Text] [Related]
2. Opsonophagocytosis-inhibiting mac protein of group a streptococcus: identification and characteristics of two genetic complexes. Lei B; DeLeo FR; Reid SD; Voyich JM; Magoun L; Liu M; Braughton KR; Ricklefs S; Hoe NP; Cole RL; Leong JM; Musser JM Infect Immun; 2002 Dec; 70(12):6880-90. PubMed ID: 12438365 [TBL] [Abstract][Full Text] [Related]
3. Antibodies to streptococcal surface enolase react with human alpha-enolase: implications in poststreptococcal sequelae. Fontán PA; Pancholi V; Nociari MM; Fischetti VA J Infect Dis; 2000 Dec; 182(6):1712-21. PubMed ID: 11069244 [TBL] [Abstract][Full Text] [Related]
4. Insight into the molecular basis of pathogen abundance: group A Streptococcus inhibitor of complement inhibits bacterial adherence and internalization into human cells. Hoe NP; Ireland RM; DeLeo FR; Gowen BB; Dorward DW; Voyich JM; Liu M; Burns EH; Culnan DM; Bretscher A; Musser JM Proc Natl Acad Sci U S A; 2002 May; 99(11):7646-51. PubMed ID: 12032337 [TBL] [Abstract][Full Text] [Related]
5. How group A Streptococcus circumvents host phagocyte defenses. Kwinn LA; Nizet V Future Microbiol; 2007 Feb; 2(1):75-84. PubMed ID: 17661677 [TBL] [Abstract][Full Text] [Related]
6. Annihilating host defense. Frank MM Nat Med; 2001 Dec; 7(12):1285-6. PubMed ID: 11726964 [No Abstract] [Full Text] [Related]
7. The streptococcal protease IdeS modulates bacterial IgGFc binding and generates 1/2Fc fragments with the ability to prime polymorphonuclear leucocytes. Söderberg JJ; von Pawel-Rammingen U Mol Immunol; 2008 Jul; 45(12):3347-53. PubMed ID: 18533265 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the role of CovR and CovS in the dissemination of Streptococcus pyogenes in invasive skin disease. Dalton TL; Hobb RI; Scott JR Microb Pathog; 2006 May; 40(5):221-7. PubMed ID: 16542816 [TBL] [Abstract][Full Text] [Related]
9. Survival of Streptococcus pyogenes within host phagocytic cells: a pathogenic mechanism for persistence and systemic invasion. Medina E; Goldmann O; Toppel AW; Chhatwal GS J Infect Dis; 2003 Feb; 187(4):597-603. PubMed ID: 12599076 [TBL] [Abstract][Full Text] [Related]
10. [Frontier of mycobacterium research--host vs. mycobacterium]. Okada M; Shirakawa T Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793 [TBL] [Abstract][Full Text] [Related]
11. IdeS, a highly specific immunoglobulin G (IgG)-cleaving enzyme from Streptococcus pyogenes, is inhibited by specific IgG antibodies generated during infection. Akesson P; Moritz L; Truedsson M; Christensson B; von Pawel-Rammingen U Infect Immun; 2006 Jan; 74(1):497-503. PubMed ID: 16369006 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of capsule enables Streptococcus pyogenes to evade immune recognition by antigen-specific antibodies directed to the G-related alpha2-macroglobulin-binding protein GRAB located on the bacterial surface. Dinkla K; Sastalla I; Godehardt AW; Janze N; Chhatwal GS; Rohde M; Medina E Microbes Infect; 2007 Jul; 9(8):922-31. PubMed ID: 17544803 [TBL] [Abstract][Full Text] [Related]
13. Insight of host immune evasion mediated by two variants of group a Streptococcus Mac protein. Agniswamy J; Lei B; Musser JM; Sun PD J Biol Chem; 2004 Dec; 279(50):52789-96. PubMed ID: 15466462 [TBL] [Abstract][Full Text] [Related]
14. Contribution of protein G-related alpha2-macroglobulin-binding protein to bacterial virulence in a mouse skin model of group A streptococcal infection. Toppel AW; Rasmussen M; Rohde M; Medina E; Chhatwal GS J Infect Dis; 2003 Jun; 187(11):1694-703. PubMed ID: 12751026 [TBL] [Abstract][Full Text] [Related]
15. IgG protease Mac/IdeS is not essential for phagocyte resistance or mouse virulence of M1T1 group A Streptococcus. Okumura CY; Anderson EL; Döhrmann S; Tran DN; Olson J; von Pawel-Rammingen U; Nizet V mBio; 2013 Jul; 4(4):. PubMed ID: 23900173 [TBL] [Abstract][Full Text] [Related]
16. Immune response to superoxide dismutase in group A streptococcal infection. McMillan DJ; Davies MR; Good MF; Sriprakash KS FEMS Immunol Med Microbiol; 2004 Apr; 40(3):249-56. PubMed ID: 15039102 [TBL] [Abstract][Full Text] [Related]
17. Understanding how leading bacterial pathogens subvert innate immunity to reveal novel therapeutic targets. Nizet V J Allergy Clin Immunol; 2007 Jul; 120(1):13-22. PubMed ID: 17606031 [TBL] [Abstract][Full Text] [Related]
18. Expression microarray and mouse virulence analysis of four conserved two-component gene regulatory systems in group a streptococcus. Sitkiewicz I; Musser JM Infect Immun; 2006 Feb; 74(2):1339-51. PubMed ID: 16428783 [TBL] [Abstract][Full Text] [Related]
19. Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus. Olive C; Ho MF; Dyer J; Lincoln D; Barozzi N; Toth I; Good MF J Infect Dis; 2006 Jun; 193(12):1666-76. PubMed ID: 16703510 [TBL] [Abstract][Full Text] [Related]
20. Progress in M-protein-based subunit vaccines to prevent rheumatic fever and rheumatic heart disease. Olive C Curr Opin Mol Ther; 2007 Feb; 9(1):25-34. PubMed ID: 17330399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]